{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:52:13Z","timestamp":1760403133080,"version":"build-2065373602"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2023-RW320-01"],"award-info":[{"award-number":["2023-RW320-01"]}]},{"name":"the CAMS Innovation Fund for Medical Science","award":["2024-I2M-C&T-B-005"],"award-info":[{"award-number":["2024-I2M-C&T-B-005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10067-025-07662-y","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T04:34:24Z","timestamp":1757046864000},"page":"4425-4434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics of dyslipidemia in patients with primary biliary cholangitis: a single-center experience in China"],"prefix":"10.1007","volume":"44","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tihong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0175-9166","authenticated-orcid":false,"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"7662_CR1","doi-asserted-by":"publisher","unstructured":"Trivella J, John BV, Levy C (2023) Primary biliary cholangitis: Epidemiology, prognosis, and treatment. Hepatol Commun 7. https:\/\/doi.org\/10.1097\/hc9.0000000000000179","DOI":"10.1097\/hc9.0000000000000179"},{"key":"7662_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-019-08772-7","volume":"59","author":"L Gao","year":"2020","unstructured":"Gao L, Wang L, Woo E et al (2020) Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends. Clin Rev Allergy Immunol 59:175\u2013194. https:\/\/doi.org\/10.1007\/s12016-019-08772-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"7662_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M (2019) Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology 69:394\u2013419. https:\/\/doi.org\/10.1002\/hep.30145","journal-title":"Hepatology"},{"key":"7662_CR4","doi-asserted-by":"publisher","first-page":"1190934","DOI":"10.3389\/fphar.2023.1190934","volume":"14","author":"JJ Li","year":"2023","unstructured":"Li JJ, Zhao SP, Zhao D et al (2023) 2023 Chinese guideline for lipid management. Front Pharmacol 14:1190934. https:\/\/doi.org\/10.3389\/fphar.2023.1190934","journal-title":"Front Pharmacol"},{"key":"7662_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","volume":"17","author":"AF Gulamhusein","year":"2020","unstructured":"Gulamhusein AF, Hirschfield GM (2020) Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nat Rev Gastroenterol Hepatol 17:93\u2013110. https:\/\/doi.org\/10.1038\/s41575-019-0226-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7662_CR6","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.cgh.2023.02.005","volume":"21","author":"C Levy","year":"2023","unstructured":"Levy C, Manns M, Hirschfield G (2023) New Treatment Paradigms in Primary Biliary Cholangitis. Clin Gastroenterol Hepatol 21:2076\u20132087. https:\/\/doi.org\/10.1016\/j.cgh.2023.02.005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7662_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1053\/j.gastro.2024.01.049","volume":"166","author":"PJ Trivedi","year":"2024","unstructured":"Trivedi PJ, Hirschfield GM, Adams DH, Vierling JM (2024) Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts. Gastroenterology 166:995\u20131019. https:\/\/doi.org\/10.1053\/j.gastro.2024.01.049","journal-title":"Gastroenterology"},{"key":"7662_CR8","doi-asserted-by":"publisher","unstructured":"Arvanitis M, Lowenstein CJ (2023) Dyslipidemia. Ann Intern Med 176:Itc81-itc96. https:\/\/doi.org\/10.7326\/aitc202306200","DOI":"10.7326\/aitc202306200"},{"key":"7662_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/gut.51.2.265","volume":"51","author":"M Longo","year":"2002","unstructured":"Longo M, Crosignani A, Battezzati PM et al (2002) Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 51:265\u2013269. https:\/\/doi.org\/10.1136\/gut.51.2.265","journal-title":"Gut"},{"key":"7662_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12876-021-01974-4","volume":"21","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Hu X, Chang J et al (2021) The liver steatosis severity and lipid characteristics in primary biliary cholangitis. BMC Gastroenterol 21:395. https:\/\/doi.org\/10.1186\/s12876-021-01974-4","journal-title":"BMC Gastroenterol"},{"key":"7662_CR11","doi-asserted-by":"publisher","unstructured":"Galoosian A, Hanlon C, Zhang J, Holt EW, Yimam KK (2020) Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches. J Clin Transl Hepatol 8:49\u201360. https:\/\/doi.org\/10.14218\/jcth.2019.00049","DOI":"10.14218\/jcth.2019.00049"},{"key":"7662_CR12","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1194\/jlr.M400229-JLR200","volume":"45","author":"PY Chang","year":"2004","unstructured":"Chang PY, Lu SC, Su TC et al (2004) Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J Lipid Res 45:2116\u20132122. https:\/\/doi.org\/10.1194\/jlr.M400229-JLR200","journal-title":"J Lipid Res"},{"key":"7662_CR13","doi-asserted-by":"publisher","unstructured":"Reshetnyak VI, Maev IV (2022) Features of Lipid Metabolism Disorders in Primary Biliary Cholangitis. Biomedicines 10. https:\/\/doi.org\/10.3390\/biomedicines10123046","DOI":"10.3390\/biomedicines10123046"},{"key":"7662_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/s1089-3261(03)00101-6","volume":"7","author":"U Leuschner","year":"2003","unstructured":"Leuschner U (2003) Primary biliary cirrhosis\u2013presentation and diagnosis. Clin Liver Dis 7:741\u2013758. https:\/\/doi.org\/10.1016\/s1089-3261(03)00101-6","journal-title":"Clin Liver Dis"},{"key":"7662_CR15","first-page":"285","volume":"10","author":"MR Ghadir","year":"2010","unstructured":"Ghadir MR, Riahin AA, Havaspour A, Nooranipour M, Habibinejad AA (2010) The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepat Mon 10:285\u2013288","journal-title":"Hepat Mon"},{"key":"7662_CR16","first-page":"89","volume":"21","author":"H Gylling","year":"1995","unstructured":"Gylling H, F\u00e4rkkil\u00e4 M, Vuoristo M, Miettinen TA (1995) Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics. Hepatology 21:89\u201395","journal-title":"Hepatology"},{"key":"7662_CR17","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/hep.510280506","volume":"28","author":"P S\u00f6r\u00f6s","year":"1998","unstructured":"S\u00f6r\u00f6s P, B\u00f6ttcher J, Maschek H, Selberg O, M\u00fcller MJ (1998) Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia. Hepatology 28:1199\u20131205. https:\/\/doi.org\/10.1002\/hep.510280506","journal-title":"Hepatology"},{"key":"7662_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/gut.11.12.1035","volume":"11","author":"A Ross","year":"1970","unstructured":"Ross A, Murphy GM, Wilkinson PA, Mills GL, Sherlock S (1970) Occurrence of an abnormal lipoprotein in patients with liver disease. Gut 11:1035\u20131037","journal-title":"Gut"},{"key":"7662_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2020.0028","volume":"27","author":"A Tanaka","year":"2021","unstructured":"Tanaka A (2021) Current understanding of primary biliary cholangitis. Clin Mol Hepatol 27:1\u201321. https:\/\/doi.org\/10.3350\/cmh.2020.0028","journal-title":"Clin Mol Hepatol"},{"key":"7662_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ecl.2022.02.008","volume":"51","author":"KR Feingold","year":"2022","unstructured":"Feingold KR (2022) Lipid and Lipoprotein Metabolism. Endocrinol Metab Clin North Am 51:437\u2013458. https:\/\/doi.org\/10.1016\/j.ecl.2022.02.008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"7662_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s11427-023-2353-0","volume":"67","author":"W Jia","year":"2024","unstructured":"Jia W, Li Y, Cheung KCP, Zheng X (2024) Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis. Sci China Life Sci 67:865\u2013878. https:\/\/doi.org\/10.1007\/s11427-023-2353-0","journal-title":"Sci China Life Sci"},{"key":"7662_CR22","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/gast.2001.23256","volume":"120","author":"AJ Sanyal","year":"2001","unstructured":"Sanyal AJ, Campbell-Sargent C, Mirshahi F et al (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183\u20131192. https:\/\/doi.org\/10.1053\/gast.2001.23256","journal-title":"Gastroenterology"},{"key":"7662_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/j.gastro.2011.09.051","volume":"142","author":"T Moustafa","year":"2012","unstructured":"Moustafa T, Fickert P, Magnes C et al (2012) Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. Gastroenterology 142:140\u201351.e12. https:\/\/doi.org\/10.1053\/j.gastro.2011.09.051","journal-title":"Gastroenterology"},{"key":"7662_CR24","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cgh.2024.01.039","volume":"22","author":"L Zheng","year":"2024","unstructured":"Zheng L, Tian S, Yang C et al (2024) Hypercholesterolemia Is Associated With Dysregulation of Lipid Metabolism and Poor Prognosis in Primary Biliary Cholangitis. Clin Gastroenterol Hepatol 22:1265\u201374.e19. https:\/\/doi.org\/10.1016\/j.cgh.2024.01.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7662_CR25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/hep.32117","volume":"75","author":"KD Lindor","year":"2022","unstructured":"Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M (2022) Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases. Hepatology 75:1012\u20131013. https:\/\/doi.org\/10.1002\/hep.32117","journal-title":"Hepatology"},{"key":"7662_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mehy.2017.11.002","volume":"110","author":"NV Bergasa","year":"2018","unstructured":"Bergasa NV (2018) The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years. Med Hypotheses 110:86\u201389. https:\/\/doi.org\/10.1016\/j.mehy.2017.11.002","journal-title":"Med Hypotheses"},{"key":"7662_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1042\/cs0630065","volume":"63","author":"TC Bartholomew","year":"1982","unstructured":"Bartholomew TC, Summerfield JA, Billing BH, Lawson AM, Setchell KD (1982) Bile acid profiles of human serum and skin interstitial fluid and their relationship to pruritus studied by gas chromatography-mass spectrometry. Clin Sci (Lond) 63:65\u201373. https:\/\/doi.org\/10.1042\/cs0630065","journal-title":"Clin Sci (Lond)"},{"key":"7662_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","volume":"56","author":"M Li","year":"2017","unstructured":"Li M, Cai SY, Boyer JL (2017) Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med 56:45\u201353. https:\/\/doi.org\/10.1016\/j.mam.2017.06.001","journal-title":"Mol Aspects Med"},{"key":"7662_CR29","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","volume":"18","author":"BL Woolbright","year":"2012","unstructured":"Woolbright BL, Jaeschke H (2012) Novel insight into mechanisms of cholestatic liver injury. World J Gastroenterol 18:4985\u20134993. https:\/\/doi.org\/10.3748\/wjg.v18.i36.4985","journal-title":"World J Gastroenterol"},{"key":"7662_CR30","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","volume":"378","author":"C Corpechot","year":"2018","unstructured":"Corpechot C, Chazouill\u00e8res O, Rousseau A et al (2018) A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. N Engl J Med 378:2171\u20132181. https:\/\/doi.org\/10.1056\/NEJMoa1714519","journal-title":"N Engl J Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07662-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07662-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07662-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:25:11Z","timestamp":1760365511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07662-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["7662"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07662-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest in this section.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest disclosure"}}]}}